AX-158

DRUG2 trials

Sponsors

Artax Biopharma Inc

Conditions

Autoimmune DiseasesPlaque PsoriasisPsoriasis

Phase 1

A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses

CompletedNCT05218434

Artax Biopharma IncAutoimmune Diseases

Start: 2021-11-17End: 2022-12-03Updated: 2024-08-23

Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis

CompletedNCT05725057

Artax Biopharma IncPlaque Psoriasis, Psoriasis

Start: 2023-11-30End: 2024-10-04Updated: 2025-10-03